攻坚中高端市场 加速全球化布局

Core Insights - New Zhi Bio, the first stock in life science instruments listed on the Beijing Stock Exchange, emphasizes the importance of innovation and capital support for small and medium-sized enterprises [1][4] Company Overview - New Zhi Bio has over 20 product lines and more than 200 product models, covering three main areas: biological sample processing, molecular biology and drug research, and laboratory automation [1] - The company has transitioned from a laboratory equipment supplier to a comprehensive service provider covering the entire process from experimentation to mass production [1][2] Product Development - The company has made technological breakthroughs in traditional ultrasonic fields, developing products suitable for industrial applications and expanding its product range in freeze-drying and temperature control equipment [2] - Customization accounts for over 20% of the business, with specialized models developed for various industries, including coal mining and pet food freeze-drying [2] Strategic Direction - New Zhi Bio is focusing on self-controlled high-end instruments and global expansion, with a strategy to build a localized service network for overseas markets [3] - The company aims to create a "research supermarket" and overall solution provider, leveraging the opportunities provided by the Beijing Stock Exchange to collaborate with leading enterprises in niche markets [5] Market Context - The domestic scientific instrument industry is experiencing significant growth, with local companies catching up to international standards in technology and application support [3] - The establishment of the Beijing Stock Exchange is seen as a timely response to the industry's development needs, providing a platform for direct financing and supporting high-quality growth for leading enterprises [4]